Sort by

Send to

Choose Destination

Links from PubMed

Items: 10


Unconventional functions for clathrin, ESCRTs, and other endocytic regulators in the cytoskeleton, cell cycle, nucleus, and beyond: links to human disease.

Brodsky FM, Sosa RT, Ybe JA, O'Halloran TJ.

Cold Spring Harb Perspect Biol. 2014 Sep 2;6(9):a017004. doi: 10.1101/cshperspect.a017004. Review.


Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit.

Ames HM, Bichakjian CK, Liu GY, Oravecz-Wilson KI, Fullen DR, Verhaegen ME, Johnson TM, Dlugosz AA, Ross TS.

J Invest Dermatol. 2011 Oct;131(10):2113-20. doi: 10.1038/jid.2011.171.


Signaling from the Golgi: mechanisms and models for Golgi phosphoprotein 3-mediated oncogenesis.

Scott KL, Chin L.

Clin Cancer Res. 2010 Apr 15;16(8):2229-34. doi: 10.1158/1078-0432.CCR-09-1695.


Structure and activity of putative intronic miRNA promoters.

Monteys AM, Spengler RM, Wan J, Tecedor L, Lennox KA, Xing Y, Davidson BL.

RNA. 2010 Mar;16(3):495-505. doi: 10.1261/rna.1731910.


Transcription regulation of caspase-1 by R393 of HIPPI and its molecular partner HIP-1.

Banerjee M, Datta M, Majumder P, Mukhopadhyay D, Bhattacharyya NP.

Nucleic Acids Res. 2010 Jan;38(3):878-92. doi: 10.1093/nar/gkp1011.


Pathogenesis of prostate cancer and hormone refractory prostate cancer.

Girling JS, Whitaker HC, Mills IG, Neal DE.

Indian J Urol. 2007 Jan;23(1):35-42. doi: 10.4103/0970-1591.30265.


Hip1r is expressed in gastric parietal cells and is required for tubulovesicle formation and cell survival in mice.

Jain RN, Al-Menhali AA, Keeley TM, Ren J, El-Zaatari M, Chen X, Merchant JL, Ross TS, Chew CS, Samuelson LC.

J Clin Invest. 2008 Jul;118(7):2459-70. doi: 10.1172/JCI33569.


The embryonic muscle transcriptome of Caenorhabditis elegans.

Fox RM, Watson JD, Von Stetina SE, McDermott J, Brodigan TM, Fukushige T, Krause M, Miller DM 3rd.

Genome Biol. 2007;8(9):R188.


It's HIP to be a hub: new trends for old-fashioned proteins.

Vecchi M, Di Fiore PP.

J Cell Biol. 2005 Jul 18;170(2):169-71. Review.


Defective downregulation of receptor tyrosine kinases in cancer.

Bache KG, Slagsvold T, Stenmark H.

EMBO J. 2004 Jul 21;23(14):2707-12. Review.

Items per page

Supplemental Content

Support Center